Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans

• Samuel O. Pine,

  Current address: Infectious Disease Research Institute, Seattle, Washington, United States of America

  Affiliations Program in Pathobiology, Department of Global Health, University of Washington, Seattle, Washington, United States of America, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• James G. Kublin,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Scott M. Hammer,

  Affiliation Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, New York, United States of America

  ⨯
• Joleen Borgerding,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Yunda Huang,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Danilo R. Casimiro,

  Affiliation Vaccine Basic Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• M. Juliana McElrath

  * E-mail: jmcelrat@fhcrc.org

  Affiliations Program in Pathobiology, Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯